185 related articles for article (PubMed ID: 36179772)
1. Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trial.
Patsiou V; Samaras A; Kartas A; Moysidis DV; Papazoglou AS; Bekiaridou A; Baroutidou A; Ziakas A; Tzikas A; Giannakoulas G
J Cardiol; 2023 Apr; 81(4):390-396. PubMed ID: 36179772
[TBL] [Abstract][Full Text] [Related]
2. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
[TBL] [Abstract][Full Text] [Related]
4. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
5. Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.
Tsai CT; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA; Chao TF
Thromb Haemost; 2024 Mar; 124(3):253-262. PubMed ID: 37776848
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
Akao M; Tsuji H; Kusano K; Matsui K; Hiramitsu S; Hatori Y; Odakura H; Ogawa H
J Cardiol; 2023 Feb; 81(2):209-214. PubMed ID: 35985869
[TBL] [Abstract][Full Text] [Related]
7. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339
[TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
9. Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study.
Lee WK; Woo SI; Hyun DK; Jung SY; Kim MS; Lee J
Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):216-226. PubMed ID: 35533394
[TBL] [Abstract][Full Text] [Related]
10. Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants.
Adam L; Feller M; Syrogiannouli L; Del-Giovane C; Donzé J; Baumgartner C; Segna D; Floriani C; Roten L; Fischer U; Aeschbacher S; Moschovitis G; Schläpfer J; Shah D; Amman P; Kobza R; Schwenkglenks M; Kühne M; Bonati LH; Beer J; Osswald S; Conen D; Aujesky D; Rodondi N;
J Thromb Haemost; 2021 Apr; 19(4):931-940. PubMed ID: 33501722
[TBL] [Abstract][Full Text] [Related]
11. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.
Brockmeyer M; Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Heinen Y; Bejinariu A; Müller P; Makimoto H; Kelm M; Wolff G
Acta Cardiol; 2021 May; 76(3):288-295. PubMed ID: 32056498
[TBL] [Abstract][Full Text] [Related]
12. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Goldhaber SZ; Bassand JP; Camm AJ; Virdone S; Pieper K; Cools F; Corbalan R; Gersh BJ; Goto S; Haas S; Misselwitz F; Parkhomenko A; Steffel J; Stepinska J; Turpie AGG; Verheugt FWA; Kayani G; Kakkar AK;
Am J Med; 2024 Feb; 137(2):128-136.e13. PubMed ID: 37918777
[TBL] [Abstract][Full Text] [Related]
14. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
Banerjee A; Benedetto V; Gichuru P; Burnell J; Antoniou S; Schilling RJ; Strain WD; Ryan R; Watkins C; Marshall T; Sutton CJ
Heart; 2020 Jan; 106(2):119-126. PubMed ID: 31601729
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry.
Verheugt FWA; Fox KAA; Virdone S; Ambrosio G; Gersh BJ; Haas S; Pieper KS; Kayani G; Camm AJ; Parkhomenko A; Misselwitz F; Ragy H; Ten Cate H; Keltai M; Kakkar AK;
Am J Med; 2023 Dec; 136(12):1187-1195.e15. PubMed ID: 37704071
[TBL] [Abstract][Full Text] [Related]
16. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
Li D; Chang P; Zhang H; Bai F; Wu Q
Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
19. Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.
Kuroda M; Tamiya E; Nose T; Ogimoto A; Taura J; Imamura Y; Fukuzawa M; Hayashi T; Akao M; Yamashita T; Lip GYH; Okumura K
JAMA Cardiol; 2022 Jun; 7(6):583-590. PubMed ID: 35416910
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis Assessing Efficacy and Safety of Vitamin K Antagonists Versus Direct Oral Anticoagulants for Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
Selvaraj V; Khan MS; Mufarrih SH; Kazimuddin M; Waheed MA; Tripathi A; Bavishi C; Hyder ON; Aronow HD; Saad M; Abbott JD
Am J Cardiol; 2023 Aug; 201():260-267. PubMed ID: 37393728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
